1 – 10 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Viral-based rodent and nonhuman primate models of multiple system atrophy : Fidelity to the human disease
(
- Contribution to journal › Article
- 2019
-
Mark
SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease
(
- Contribution to journal › Article
-
Mark
Enhanced Dopamine in Prodromal Schizophrenia (EDiPS) : a new animal model of relevance to schizophrenia
(
- Contribution to journal › Article
- 2018
-
Mark
Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs
(
- Contribution to journal › Article
- 2017
-
Mark
Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study.
(
- Contribution to journal › Letter
-
Mark
A doctor's dilemma
(
- Contribution to journal › Article
- 2014
-
Mark
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
(
- Contribution to journal › Article
- 2013
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article